HAS approves improved vaccine Gardasil 9 for cervical cancer
Date: 2017-10-12   Author: Pankaj Singh  Category: #market

HAS approves improved vaccine Gardasil 9 for cervical cancer

The High Authority of Health (HAS) has approved a rather effective and improved vaccine against the infection with human papillomavirus (HPV) in the France market, called Gardasil 9. The vaccine may, in all probability, help prevent the onset of HPV, a common STI (sexually transmitted infection) that can cause serious ailments such as cervical cancer and genital warts.

In recent times, cervical cancer of the uterus has depicted a survival rate of lesser than 5 years for women after diagnosis and approximately, 1,000 women lose their lives per year owing to the occurrence of this cancer. As per statistics, HPV infection may lead to various other kinds of cancers as well - 1 in 100 cancers of the anus, 500 cancers of vulva, and 300 cancers of vagina. According to the results obtained from clinical trials, the vaccination against these viruses is likely to prevent 90% chances of being detected with cervical cancer.

The High Authority of Health has also unearthed that the Gardasil 9 formula includes virus strains 6, 11, 16, 18 and serotypes 31, 33, 45, 52, and 58, which have considerably improved the efficacy of the new HPV vaccine.

Taking into account the higher prevalence of HPV among the youth, the French government has decided to promote HPV vaccines across the nation. Initially, the High Authority of Health (HAS) has targeted only 20% of young women for the HPV vaccination, however, the goal set under the Cancer Plan 2014-19 aims to target 60% of young women for the same.

A year before, the High Council for Public Health (HCSP) conveyed that the results obtained from comparable clinical trials carried out on Gardasil and Gardasil 9 depicted a noticeable enhancement in the latter, on account of the inclusion of five new HPV strains in the vaccine, which will lead to more than 96% reduction in HPV infections. Considering the effectiveness of Gardasil 9 as compared to its earlier version, the High Authority of Health (HAS) has officially recommended this vaccine for treatment of cervical cancer.



About Author


Pankaj Singh

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More from Pankaj


Post Recommendents

Email Address Verifier Market Growth, Trends, And Forecast (2020- 2025)
Author: Sachin Pashte

The Email Address Verifier market report, added by Market Study Report, LLC, descriptively covers the present & future growth trends, in addition to highlighting the global expanse of this industry and elaborating the regional share and contri...


Wearable and Implantable Medical Devices Market Expected to Witness the Highest Growth 2025
Author: Sachin Pashte

Recently, Market Study Report, LLC, added a research on the ' Wearable and Implantable Medical Devices market' which encompasses significant inputs with respect to market share, market size, regional landscape, contributing players, and re...


Customer Relationship Management (CRM) Outsourcing Market Analysis, Revenue, Price, Market Share, Growth Rate, Forecast to 2025
Author: Sachin Pashte

Market Study Report has added a new report on Customer Relationship Management (CRM) Outsourcing Market Analysis that elucidates an in-depth synopsis of this business vertical over the forecast period. The report is inclusive of the prominent indu...